Compounded tirzepatide dosing: what the concentration math actually means

What did @risinghealthreport actually say?

Here is the uncomfortable truth: the transcript for this video is not a health explanation. It is rap lyrics. Lines like "I rock like pebble, jump for your sheet" and "come out like heavy metal" have nothing to do with compounded tirzepatide dosing, concentration math, or GLP-1 pharmacology.

The caption, however, does make a real claim worth addressing: that compounded tirzepatide is "mixed at varying strengths," meaning the same milligram dose can require different injection volumes depending on the concentration of the vial. That is a legitimate and actually important point for patients using compounded GLP-1 medications. The problem is the video's audio does not support or explain it at all. We are fact-checking the caption's claim because the spoken content contains zero medical information.

Does the science back this up?

Yes, the caption's core pharmacology claim is correct, even if no one in the video actually said it out loud. Concentration and dose are distinct variables, and conflating them is a genuine patient safety issue.

Compounded tirzepatide is prepared by 503A and 503B pharmacies at a range of concentrations, commonly between 2.5 mg/mL and 10 mg/mL, though this varies widely by compounder. A patient prescribed 2.5 mg who has a 5 mg/mL vial injects 0.5 mL. The same patient with a 2.5 mg/mL vial injects 1.0 mL. Doubling the wrong variable means doubling the dose. That is not a theoretical risk. The FDA's 2024 guidance on compounded semaglutide and tirzepatide specifically flagged dosing errors related to unit confusion and concentration variability as an active safety concern. Davies et al. (2023, Diabetes Care) documented that medication errors in injectable GLP-1 therapy are disproportionately tied to patient misunderstanding of volume-to-dose conversion.

What did they get wrong (or right)?

The caption got the concept right. Dose does not equal volume when concentrations differ. That is just basic pharmaceutical math and it matters enormously for patients self-injecting at home without clinical supervision at each step.

What the video got wrong, structurally, is that the actual audio content provides no educational value whatsoever. If someone watched this with the sound on and captions off, they would learn nothing about tirzepatide. If the goal was GLP-1 education, as the hashtags suggest, using a rap audio track unrelated to the topic is a confusing choice at best and potentially harmful at worst, since many TikTok viewers process video and audio together rather than reading captions closely.

There is also no mention of the regulatory context: compounded tirzepatide is not FDA-approved, it is not equivalent to Zepbound or Mounjaro, and concentration variability exists precisely because compounders are not subject to the same standardization requirements as branded manufacturers. Leaving that out is a meaningful omission for a video tagged under "medication safety."

What should you actually know?

If you are using compounded tirzepatide, the concentration printed on your vial is not optional reading. It is the number that determines how much you inject. "2.5 mg dose" tells you the drug amount. It does not tell you the volume.

Your prescribing provider or dispensing pharmacy should give you explicit instructions: at X mg/mL concentration, a 2.5 mg dose equals Y mL. If they did not give you that information, ask before you inject. The Institute for Safe Medication Practices (ISMP) has repeatedly flagged insulin-style dosing errors in GLP-1 therapies as a systemic problem, not an edge case.

Also worth knowing: compounded tirzepatide is not the same as Zepbound or Mounjaro. The FDA has not evaluated compounded versions for safety, efficacy, or manufacturing consistency. That does not mean compounded options have no role, but patients deserve to understand the distinction. A video with 6,700 views on a topic this specific has real influence, and that influence comes with responsibility to be accurate and complete.